A Feasibility Trial Using Hydroxyurea for Secondary Prevention of Silent Cerebral Infracts in Children with Sickle Cell Disease

Grant

Awarded By

Total Award Amount

  • 60000.00

    • Direct Costs

  • 60000.00

    • Sponsor Award Id

    • Contributor

  • Jeffrey Lebensburger   Principal Investigator